| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S00213-005-0185-2 |
| P698 | PubMed publication ID | 16362406 |
| P50 | author | Inger Sundström-Poromaa | Q21261852 |
| Torbjörn C. Bäckström | Q78148663 | ||
| P2093 | author name string | Anna-Carin N-Wihlbäck | |
| P2860 | cites work | Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit | Q24321527 |
| Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself | Q28138046 | ||
| Neuroactive steroids | Q28181775 | ||
| Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
| Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice | Q28288210 | ||
| Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat | Q28345578 | ||
| Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review | Q28361007 | ||
| Alcohol, allopregnanolone and aggression in mice | Q32174698 | ||
| Neuroendocrine influences and repercussions of the menopause | Q33658528 | ||
| Preliminary evidence for an association between aggressive and hostile behaviour and 3alpha,5alpha-tetrahydroprogesterone plasma levels in schizophrenia. | Q33708658 | ||
| Neural oxytocinergic systems as genomic targets for hormones and as modulators of hormone-dependent behaviors | Q33715652 | ||
| Is premenstrual dysphoric disorder a distinct clinical entity? | Q33934979 | ||
| Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women | Q34086512 | ||
| Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study | Q34148070 | ||
| Oral oestrogen replacement therapy versus placebo for hot flushes | Q34202745 | ||
| Relationship between the anesthetic and gestagenic action and estrous behavior-inducing activity of different progestins | Q34224526 | ||
| Modulation of the GABA receptor complex by a steroid anaesthetic | Q34245731 | ||
| A progesterone metabolite stimulates the release of gonadotropin-releasing hormone from GT1-1 hypothalamic neurons via the gamma-aminobutyric acid type A receptor. | Q34376770 | ||
| Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor | Q34384840 | ||
| Stress and neuroactive steroids | Q34400471 | ||
| Neuroactive steroids and central nervous system disorders. | Q34400504 | ||
| A-ring reduced derivatives of two synthetic progestins induce anxiolytic effects in ovariectomized rats. | Q48419244 | ||
| GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid | Q48472565 | ||
| Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects | Q48507572 | ||
| Plasticity in fast synaptic inhibition of adult oxytocin neurons caused by switch in GABA(A) receptor subunit expression | Q48589858 | ||
| Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system | Q48590882 | ||
| Development of tolerance in mice to the sedative effects of the neuroactive steroid minaxolone following chronic exposure. | Q48633191 | ||
| Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states | Q48643545 | ||
| Sex differences in the effects of gonadectomy and acute swim stress on GABAA receptor binding in mouse forebrain membranes | Q48679749 | ||
| Aging of Hypothalamic-Pituitary-Ovarian Function in the Rat | Q48736801 | ||
| Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects | Q48785721 | ||
| The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause | Q49026598 | ||
| Gamma-aminobutyric acidA receptors mediate 3 alpha-hydroxy-5 alpha-pregnan-20-one-induced gonadotropin secretion | Q49042941 | ||
| Pubertal changes in hormone levels and depression in girls. | Q50654263 | ||
| Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. | Q50882535 | ||
| Negative mood changes during hormone replacement therapy: a comparison between two progestogens. | Q51072055 | ||
| Effects of triazolam at three phases of the menstrual cycle. | Q51085902 | ||
| Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. | Q51097225 | ||
| Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. | Q51107637 | ||
| Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. | Q51139011 | ||
| Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. | Q51140020 | ||
| State-dependent alterations in the perception of life events in menstrual-related mood disorders. | Q51170009 | ||
| A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids. | Q51178136 | ||
| Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. | Q51180858 | ||
| Mood changes in the first three weeks after childbirth. | Q51252904 | ||
| Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo | Q51321924 | ||
| Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats. | Q51370996 | ||
| Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. | Q51391113 | ||
| Allopregnanolone concentrations and premenstrual syndrome. | Q51414525 | ||
| Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics. | Q51458718 | ||
| Allopregnanolone in women with premenstrual syndrome. | Q51516389 | ||
| Allopregnanolone levels and symptom improvement in severe premenstrual syndrome | Q44156727 | ||
| Central-nervous side effects of midazolam during transesophageal echocardiography | Q44202021 | ||
| Severe behavioral complications following intracarotid sodium amobarbital injection: implications for hemispheric asymmetry of emotion | Q44316796 | ||
| Progesterone effects during sequential hormone replacement therapy | Q44422417 | ||
| Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women | Q44424884 | ||
| Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy | Q44427437 | ||
| Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study | Q44441471 | ||
| Arousal and stress response across the menstrual cycle in women with three perimenstrual symptom patterns | Q44551310 | ||
| The contraceptive agent Provera enhances GABA(A) receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids? | Q44645630 | ||
| Hormones and menopausal status as predictors of depression in women in transition to menopause | Q44714898 | ||
| Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder | Q44864438 | ||
| Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats. | Q44995444 | ||
| Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density | Q45003478 | ||
| Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women | Q45052549 | ||
| Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone | Q45096057 | ||
| Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being | Q45117741 | ||
| Estrogen improves psychological function in asymptomatic postmenopausal women | Q46492621 | ||
| Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. | Q46497183 | ||
| Progesterone metabolite allopregnanolone in women with premenstrual syndrome | Q46518358 | ||
| Allopregnanolone and pregnanolone are produced by the human corpus luteum | Q46527341 | ||
| Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil | Q46683708 | ||
| Lactate infusion induces panic attacks in patients with premenstrual syndrome | Q47292304 | ||
| Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences | Q47976555 | ||
| Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain | Q48135017 | ||
| Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function | Q48272302 | ||
| Stress and neurosteroids in adult and aged rats | Q48287992 | ||
| Benzodiazepine sensitivity in normal human subjects | Q48341273 | ||
| Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain | Q48344217 | ||
| Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome | Q34452948 | ||
| Three patterns of catamenial epilepsy | Q34467397 | ||
| Hormonal and genetic influences underlying arousal as it drives sex and aggression in animal and human brains | Q35163872 | ||
| Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance | Q35254149 | ||
| Neurosteroids, GABAA receptors, and escalated aggressive behavior | Q35580605 | ||
| Identification and characterization of a pregnane steroid recognition site that is functionally coupled to an expressed GABAA receptor | Q36460919 | ||
| Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. | Q36650876 | ||
| Function and pharmacology of multiple GABAA receptor subunits | Q37175882 | ||
| Neurosteroids: a new function in the brain | Q37364348 | ||
| Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain | Q37517966 | ||
| Restoration of ovulatory cycles by young ovarian grafts in aging mice: potentiation by long-term ovariectomy decreases with age. | Q37690453 | ||
| Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects | Q38596469 | ||
| The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors | Q39238416 | ||
| Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study | Q39495316 | ||
| Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome | Q39507988 | ||
| Ineffectiveness of progesterone suppository treatment for premenstrual syndrome | Q39515990 | ||
| Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives | Q39538079 | ||
| Oestrogen therapy and the menopausal syndrome | Q39582567 | ||
| Sex Differences and the Epidemiology of Depression | Q39617578 | ||
| Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. | Q40417870 | ||
| Predictors, prodromes and incidence of postpartum depression | Q40697956 | ||
| Neurosteroids: biochemistry, modes of action, and clinical relevance | Q40749476 | ||
| Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy | Q40799582 | ||
| "Menstrual" migraine: towards a definition | Q40950772 | ||
| A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons | Q40958918 | ||
| Oral administration of micronized progesterone: a review and more experience. | Q41050125 | ||
| Severe negative emotional reactions in intracarotid sodium amytal procedures: further evidence for hemispheric asymmetries? | Q41159289 | ||
| Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms | Q41275700 | ||
| Alcohol, GABAA-benzodiazepine receptor complex, and aggression. | Q41448306 | ||
| Estrogen effects on cognition in menopausal women | Q41471939 | ||
| Evidence for a role for the neurosteroid allopregnanolone in the modulation of reproductive function in female rats. | Q42479219 | ||
| Progesterone withdrawal I: pro-convulsant effects. | Q42539311 | ||
| Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety. | Q42541290 | ||
| Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one | Q42614851 | ||
| The effects of oestrogens and progestogens on the postmenopausal endometrium | Q43420164 | ||
| The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats | Q43574363 | ||
| Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder | Q43581426 | ||
| Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder | Q43593944 | ||
| Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy | Q43642175 | ||
| Tolerance to the anticonvulsant activity of midazolam and allopregnanolone in a model of picrotoxin seizures | Q43705245 | ||
| Neuroactive steroids, their precursors and polar conjugates during parturition and postpartum in maternal blood: 2. Time profiles of pregnanolone isomers | Q43724660 | ||
| The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat. | Q43737573 | ||
| Autoradiographic localization of hormone-concentrating cells in the brain of the female rhesus monkey | Q43767478 | ||
| The effects of diazepam (valium) and aggressive disposition on human aggression: an experimental investigation | Q43870872 | ||
| The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy | Q43934260 | ||
| Initial sensitivity, tolerance and cross-tolerance to allopregnanolone- and ethanol-induced hypothermia in selected mouse lines | Q44067283 | ||
| Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. | Q51533350 | ||
| Acute effects of triazolam in women: relationships with progesterone, estradiol and allopregnanolone. | Q51547214 | ||
| Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. | Q51576472 | ||
| Infusions of diazepam and allopregnanolone into the midbrain central gray facilitate open-field behavior and sexual receptivity in female rats. | Q51596563 | ||
| A novel radioimmunoassay of allopregnanolone. | Q51612417 | ||
| Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. | Q51620610 | ||
| Inhibitory effect of 5 beta-pregnan-3 alpha-o1-20-one on gonadotropin-releasing hormone gene expression in the male rat. | Q51627953 | ||
| Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. | Q51732016 | ||
| Pregnanolone emulsion. A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent. | Q51738382 | ||
| Foot-shock stress and anxiogenic beta-carbolines increase t-[35S]butylbicyclophosphorothionate binding in the rat cerebral cortex, an effect opposite to anxiolytics and gamma-aminobutyric acid mimetics. | Q51764306 | ||
| The anaesthetic potency of 3 alpha-hydroxy-5 alpha-pregnan-20-one and 3 alpha-hydroxy-5 beta-pregnan-20-one determined with an intravenous EEG-threshold method in male rats. | Q51788949 | ||
| Emotional outbursts and post-traumatic stress disorder during intracarotid amobarbital procedure. | Q52027745 | ||
| Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS). | Q52061362 | ||
| Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. | Q52544780 | ||
| Mood, sexuality, hormones and the menstrual cycle. I. Changes in mood and physical state: description of subjects and method. | Q53725795 | ||
| Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. | Q55067913 | ||
| An update on GABAA receptors | Q56601749 | ||
| Cyclical mood changes as in the Premenstrual tension Syndrome during Sequential Estrogen-Progestagen Postmenopausal Replacement Therapy | Q58449421 | ||
| Affective changes with estrogen and androgen replacement theraphy in surgically menopausal women | Q64356866 | ||
| Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer | Q68307960 | ||
| The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome | Q69715076 | ||
| Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo | Q70407322 | ||
| Menstrually Related Disorders: points of consensus, debate, and disagreement | Q70477299 | ||
| Estradiol and testosterone in specific regions of the human female brain in different endocrine states | Q70836584 | ||
| Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder | Q71043865 | ||
| Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome | Q71240434 | ||
| Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms | Q71474718 | ||
| Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration | Q71661477 | ||
| Effects of hormonal replacement therapy on the postural balance among postmenopausal women | Q71832890 | ||
| A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density | Q72243376 | ||
| A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome | Q72335672 | ||
| Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA | Q73148510 | ||
| Clinical pain perception and hormone replacement therapy in postmenopausal women experiencing orofacial pain | Q73932922 | ||
| The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters | Q74315831 | ||
| Catamenial epilepsy | Q74334819 | ||
| Influence of endogenous progesterone on alprazolam pharmacodynamics | Q77816500 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | menstrual cycle | Q83864 |
| P304 | page(s) | 388-401 | |
| P577 | publication date | 2005-12-15 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders | |
| P478 | volume | 186 |
| Q49598739 | A novel therapeutic approach for treatment of catamenial epilepsy |
| Q28729887 | Beyond the HPA Axis: Progesterone-Derived Neuroactive Steroids in Human Stress and Emotion |
| Q33822091 | Changes in brain size during the menstrual cycle |
| Q38413567 | Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD. |
| Q37795699 | Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders |
| Q46945437 | How progesterone impairs memory for biologically salient stimuli in healthy young women. |
| Q37456477 | Influence of 17beta-estradiol and progesterone on GABAergic gene expression in the arcuate nucleus, amygdala and hippocampus of the rhesus macaque |
| Q30488137 | Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder |
| Q36102032 | Mechanisms of neurosteroid interactions with GABA(A) receptors. |
| Q30431992 | Menstrual cycle-related exacerbation of disease |
| Q35971833 | Neurosteroids and GABA-A Receptor Function |
| Q33792908 | Neurosteroids and GABAergic signaling in health and disease |
| Q35919515 | Personality Traits of Suicidality Are Associated with Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Suicidal Women Sample |
| Q28274391 | Progesterone receptors: form and function in brain |
| Q48131565 | Progesterone selectively increases amygdala reactivity in women |
| Q36737983 | Sex steroid-related candidate genes in psychiatric disorders. |
| Q26851296 | The role of ovarian hormone-derived neurosteroids on the regulation of GABAA receptors in affective disorders |
Search more.